Foresite Capital Management VI LLC
CIK 2013341
13F filing for Q2 2026・No. 3,364
- Holdings
- US$642.58M
- Quarter change
- +US$182.3M
- Entries
- 23
- Net bought (estimate)
- +US$116.54M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 8
- Sold out 2
- Cut 1
- Added 6
- Corporate actions 0
- Unchanged 8
Largest holdings
23 stocks worth US$642.58M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| CG Oncology, Inc.COM | Added | 2,369,574 | US$168.36M | 26.20% |
| ALUMIS INC.COM | Unchanged | 4,247,670 | US$119.53M | 18.60% |
| Seaport Therapeutics, Inc.COM | New | 1,779,521 | US$38.65M | 6.02% |
| DNLIDenali Therapeutics Inc.COM | Added | 1,396,771 | US$35.92M | 5.59% |
| Celldex Therapeutics, Inc.COM | Added | 879,713 | US$32.73M | 5.09% |
| AGIOS PHARMACEUTICALS, INC.COM | Added | 785,000 | US$29.13M | 4.53% |
| Corvus Pharmaceuticals, Inc.COM | Unchanged | 1,831,233 | US$27.36M | 4.26% |
| Parabilis Medicines, Inc.COM | New | 999,044 | US$27.34M | 4.26% |
| GH Research PLCORD | Added | 940,493 | US$25.28M | 3.93% |
| Jade Biosciences, Inc.COM | Added | 886,667 | US$19.7M | 3.07% |
Sign in (free) to see its 23 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.